Literature DB >> 2260460

Assay-dependent results of immunoassayable spontaneous 24-hour growth hormone secretion in short children.

M L Granada1, A Sanmartí, A Lucas, I Salinas, A Carrascosa, M Foz, L Audí.   

Abstract

Forty-eight children, referred for evaluation of short stature, underwent 24-hour spontaneous growth hormone (GH) secretion studies. The GH level in pooled sera was assessed for each child, using up to 11 commercial immunoassays. In a group of 15 children, the mean GH values obtained by nine of the assays were compared with the mean value given by a polyclonal radioimmunoassay (RIA) from Sorin: four gave higher results (p less than 0.0001), three gave comparable results and two gave lower results (p less than 0.001). The assay yielding the highest results (Nichols: 5.9 +/- 2.3 ng/ml, mean +/- SD) gave values that were approximately triple those obtained by the assay yielding the lowest results (Hybritech: 1.8 +/- 0.8 ng/ml; p less than 0.0001); both of these are monoclonal immunoradiometric assays (IRMAs). The GH concentrations measured in 24-hour pools from 32 children using a monoclonal IRMA from Biomérieux were similar to those obtained using a polyclonal RIA from Farmos (2.8 +/- 1.1 ng/ml and 2.9 +/- 1.4 ng/ml, respectively) but significantly lower than those measured by another polyclonal RIA from Sorin (3.5 +/- 1.5 ng/ml). Two polyclonal assays (Biomérieux and Sorin) were then used to measure the GH levels in all of the 30-minute samples and in the day, night and 24-hour pools from the secretion studies of 22 children. The ratio of the results of the two assays remained fairly constant for a given child (although the GH levels in different 30-minute samples differed considerably). However, the ratios between different children showed quite wide variation (from 2.03 to 1.04).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2260460     DOI: 10.1111/j.1651-2227.1990.tb11675.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  7 in total

Review 1.  Biochemical investigations in diagnosis and follow up of acromegaly.

Authors:  Katharina Schilbach; Christian J Strasburger; Martin Bidlingmaier
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

2.  Quantification of day-to-day variability in growth hormone levels in acromegaly.

Authors:  Andrew Kraftson; Ariel Barkan
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

3.  Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders.

Authors:  M Bozzola; M Zecca; F Locatelli; G Radetti; S Pagani; M Autelli; L Tatò; P Chatelain
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

Review 4.  Current diagnosis of acromegaly.

Authors:  Rocio A Cordero; Ariel L Barkan
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 5.  Defining normalcy of the somatotropic axis: an attainable goal?

Authors:  Ariel L Barkan
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

Review 6.  Growth hormone assays: current methodologies and their limitations.

Authors:  Martin Bidlingmaier; Christian J Strasburger
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

7.  ELISA for Determination of Human Growth Hormone: Recognition of Helix 4 Epitopes.

Authors:  Juliana F. Moura; Luiz DeLacerda; Romolo Sandrini; Fernanda M. Borba; Denise N. Castelo; Elis R. Sade; Sandra Sella; João C. Minozzo; Luis G. Callefe; Bonald C. Figueiredo
Journal:  J Biomed Biotechnol       Date:  2004
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.